Articles related to TYPE 2 DIABETES

As cannabis becomes more widely available and socially accepted and legalized in various jurisdictions, it is essential to understand its potential health risks and the need for health care professionals to routinely talk to patients about cannabis use.

The average change in HbA1c from initial visit to discharge was –2.68% in patients who graduated and –0.47% in those who were discharged—quite significant, given that every 1% reduction in HbA1c translates into a 14% decrease in the risk for heart attack.

“We found that while the liver and intestines need high concentrations of the drug to respond, the brain reacts to much lower levels.”

Tirzepatide use was associated with a little more than double the odds—115 percent—of developing PDR compared with those not on the medication, with most cases occurring in patients who already had mild retinal damage from diabetes.

Large-scale propensity-matched analysis reveals differential cardiovascular outcomes between GLP-1 receptor agonists and SGLT-2 inhibitors in routine clinical practice.

Four-month mitoquinone supplementation reversed early indicators of cardiac metabolic stress in Type 2 diabetes patients, improving heart energy efficiency by 15% compared to standard treatment alone.